UK government plans to widen the roll out of the Innova lateral flow test without supporting evidence risks serious harm, warn experts in The BMJ today. More than £1 billion have been spent on ...
The proportion of people with current covid-19 infection missed by the Innova lateral flow test (LFT) is substantial enough to be of clinical importance, particularly when testing people without ...
The proportion of COVID-19 infections missed by the Innova lateral flow test (LFT) are “substantial enough to be of clinical importance” according to an analysis published in The BMJ. The study by ...
UK government plans to widen the roll out of the Innova lateral flow test without supporting evidence risks serious harm, warn experts in The BMJ today. More than £1 billion have been spent on ...
When the coronavirus pandemic first took hold, trying to get a COVID test was like trying to get Glastonbury tickets. Hard to come by is an understatement. But now, well over a year on, a key part of ...
The proportion of people with current COVID-19 infection missed by the Innova lateral flow test (LFT) is substantial enough to be of clinical importance, particularly when testing people without ...
UK government plans to widen the roll out of the Innova lateral flow test without supporting evidence risks serious harm, warn experts in The BMJ today. More than £1 billion have been spent on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results